Ocugen, Inc. (OCGN)
1.005
-0.04
(-3.37%)
USD |
NASDAQ |
Oct 07, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Ocugen Price : 1.005 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 1.05 | 1.12 | 1.04 | 1.04 | 5.294M |
| Oct 05, 2026 | 1.03 | 1.05 | 1.00 | 1.04 | 5.496M |
| Oct 02, 2026 | 1.04 | 1.04 | 1.01 | 1.02 | 3.447M |
| Oct 01, 2026 | 1.03 | 1.05 | 1.00 | 1.00 | 5.058M |
| Sep 30, 2026 | 1.09 | 1.10 | 1.01 | 1.03 | 7.323M |
| Sep 29, 2026 | 1.05 | 1.10 | 1.04 | 1.09 | 7.556M |
| Sep 28, 2026 | 1.025 | 1.05 | 1.00 | 1.03 | 4.860M |
| Sep 25, 2026 | 1.06 | 1.09 | 1.015 | 1.02 | 8.695M |
| Sep 24, 2026 | 0.9965 | 1.02 | 0.9701 | 1.00 | 5.622M |
| Sep 23, 2026 | 1.06 | 1.06 | 0.9816 | 1.00 | 12.17M |
| Sep 22, 2026 | 1.05 | 1.08 | 1.03 | 1.04 | 5.713M |
| Sep 21, 2026 | 1.05 | 1.08 | 1.02 | 1.03 | 4.156M |
| Sep 18, 2026 | 1.025 | 1.085 | 1.00 | 1.06 | 14.76M |
| Sep 17, 2026 | 1.02 | 1.06 | 1.01 | 1.03 | 3.915M |
| Sep 16, 2026 | 0.997 | 1.015 | 0.97 | 0.9984 | 9.094M |
| Sep 15, 2026 | 1.05 | 1.06 | 0.98 | 0.9935 | 12.65M |
| Sep 14, 2026 | 1.035 | 1.07 | 1.00 | 1.06 | 6.680M |
| Sep 11, 2026 | 1.04 | 1.06 | 1.01 | 1.02 | 6.471M |
| Sep 10, 2026 | 1.095 | 1.095 | 1.01 | 1.025 | 22.25M |
| Sep 09, 2026 | 1.31 | 1.320 | 1.06 | 1.065 | 39.26M |
| Sep 08, 2026 | 1.35 | 1.36 | 1.32 | 1.33 | 2.819M |
| Sep 04, 2026 | 1.32 | 1.38 | 1.31 | 1.36 | 3.568M |
| Sep 03, 2026 | 1.335 | 1.35 | 1.30 | 1.35 | 2.416M |
| Sep 02, 2026 | 1.34 | 1.38 | 1.31 | 1.32 | 4.285M |
| Sep 01, 2026 | 1.33 | 1.34 | 1.29 | 1.33 | 2.181M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.64 |
| Gilead Sciences, Inc. | 146.82 |
| MannKind Corp. | 3.455 |
| Nektar Therapeutics | 40.09 |
| Vertex Pharmaceuticals, Inc. | 505.57 |
Price Related Metrics
| PS Ratio | 70.36 |
| PEG Ratio | -0.1360 |
| Earnings Yield | -25.34% |
| Market Cap | 340.74M |
| PEGY Ratio | -0.1360 |